DOI: 10.25881/BPNMSC.2020.85.96.024

Authors

Bolomatov N.V.

Pirogov National Medical and Surgical Center, Moscow

Abstract

In recent years, cutter embolization has become widely used in clinical practice. The development of new embolizing agents and technologies has made it possible to perform a large number of clinical tasks. There are a number of classifications that allow you to subdivide embolization materials according to various criteria. An analysis of the previously developed classifications of embolizing materials is given, as well as a new version of the classification of embolizing materials, taking into account the following features: the ability to resorption, the mechanism of influence on the vascular wall, physical and chemical properties.

Keywords: embolizing agents, embolizing materials, catheter embolization, intravascular embolization, occlusion.

References

1. Dawbarn R. The starvation operation for malignancy in the external carotid area. JAMA. 1904;43:792–795. Doi: 10,1001 / jama.1904.92500120002g.

2. Brooks B. The treatment of traumatic arterio-venous fistula. South Med J. 1930;23:100–106.

3. Speakman TJ. Internal occlusion of a carotid-cavernous fistula. J Neurosurg. 1964;21:303–315.

4. Dick R. Therapeutic angiographic embolization. Br. J. Radiol. 1977;50:241–242. Doi: 10.1259/0007-1285-50-592-241.

5. Serbinenko FA. Kateterizatsiya i okklyuziya bol'shikh tserebral'nykh sosudov i perspektivy razvitiya sosudistoi neirokhirurgii. Voprosy neirokhirurgii. 1971;35(5):17–27.

6. Tadavarthy SM, Knight L, Ovitt TW, et al. Therapeutic transcatheter arterial embolization. Radiology. 1974;111:13–16.

7. Gianturco C, Anderson JH, Wallace S. Mechanical devices for arterial occlusion. Am J Roentgenol Radium Ther Nucl Med. 1975;124:428–438.

8. Rose SC. Mechanical devices for arterial occlusion and therapeutic vascular occlusion utilizing steel coil technique: clinical applications. AJR Am J Roentgenol. 2009;192:321–324. Doi: 10.2214/AJR.08.1610.

9. Guimaraes M, Wooster M. Onyx (ethylene-vinyl alcohol copolymer) in peripheral applications. Semin Intervent Radiol. 2011;28:350–356. Doi:10.1055/s-0031-1284462.

10. Laurent A, Beaujeux R, Wassef M, et al. Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation. AJNR Am J Neuroradiol. 1996;17:533–540.

11. Lewis AL, Gonzalez MV, Lloyd AW, et al. DC Bead: in-vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol. 2006;17:335–342. Doi:10.1097/01.RVI.0000195323.46152.B3.

12. Yan ZP, Lin G, Zhao HY, et al. An experimental study and clinical pilot trials on yttrium-90 glass microspheres through the hepatic artery for treatment of primary liver cancer. Cancer. 1993;72:3210–3215. Doi: 10.1002/1097-0142(19931201)72:11<3210::aid-cncr2820721113>3.0.co;2-6.

13. Weng L, Rostambeigi N, Zantek ND, et al. An in situ forming biodegradable hydrogel-based embolic agent for interventional therapies. Acta Biomater. 2013;9:8182–8191. Doi: 10.1016/j.actbio.2013.06.020.

14. Owen RJ, Nation PN, Polakowski R, et al. A preclinical study of the safety and efficacy of Occlusin 500 artificial embolization device in sheep. Cardiovasc Intervent Radiol. 2012;35:636–644. Doi: 10.1007/s00270-011-0218-7.

15. Karelin MI. Obosnovanie rentgenoendovaskulyarnoi ferromagnitnoi embolizatsii i lokal'noi VCh-gipertermii pri pochechno-kletochnom rake IV stadii. Eksperimental'nye issledovaniya i klinicheskie nablyudeniya. [dissertation] Saint Petersburg; 1998.

16. Rizk G, Atallah N, Bridi G. Renal arteriovenous fistula treated by catheter embolization. Br. J. Radiol. 1973;46:222–224. Doi: 10.1259 / 0007-1285-46-543-222.

17. Dubois J, Sebag G, De Prost Y, et al. The treatment of soft tissue venous malformation in children: percutaneous sclerotherapy with Ethibloc. Radiology. 1991;180:195–198. Doi: 10.1148 / radiology.180.1.2052693.

18. Lang E. Transcatheter embolization of pelvic vessels for control of intractable hemorrhage. Radiology. 1981;140(2):331–339. Doi: 10.1148 / radiology.140.2.7196055.

19. Nguyen M, Lee D. Injectable biodegradable hydrogels. Macromol. Biosci. 2010;10:563–579. Doi: 10.1002/mabi.200900402.

20. Andrews R, Binkert C. Relative rates of blood flow reduction during transcatheter arterial embolization with tris-acryl gelatin microspheres or polyvinyl alcohol: quantitative comparison in a swine model. J Vasc Interv Radiol. 2003;14:1311–131. Doi: 10.1097/01.rvi.0000092903.31640.70.

21. Vaidya S, Tozer KR, Chen J. An overview of embolic agents. Semin Intervent Radiol. 2008;25(3):204–215. Doi: 10.1055/s-0028-1085930.

22. Volkov OV. Osnovy angiografii. 20 p.

23. Hoshino J, Ubara Y, Suwabe T, et al. Intravascular embolization therapy in patients with enlarged polycystic liver. Am J Kidney Dis. 2014;63(6):937–944. Doi: 10.1053/j.ajkd.2014.01.422.

24. Guimaraes M, Lencioni R, Gary P. Embolization Therapy: Principles and Clinical Applications. Wolters Kluwer Health; 2015.

25. Order of the Ministry of Health of the Russian Federation N 4-n “Ob utverzhdenii nomenklaturnoi klassifikatsii meditsinskikh izdelii” dated 06 June 2012.

For citation

Bolomatov N.V. Classification of embolizing agents. Bulletin of Pirogov National Medical & Surgical Center. 2020;15(3-2):133-135. (In Russ.) https://doi.org/10.25881/BPNMSC.2020.85.96.024